• Plerixafor (AMD3100): Optimizing CXCR4-Axis Research Workflo

  2026-07-20

  Plerixafor (AMD3100) remains the gold-standard CXCR4 antagonist for dissecting the SDF-1/CXCR4 axis in cancer, stem cell, and immunology models. This guide delivers actionable experimental workflows, advanced troubleshooting, and insights from recent comparative research to empower high-impact studies.

• Novel HER2 Inhibitors Target EMT in Breast Cancer: Q7j vs. M

  2026-07-19

  The reference study presents a series of novel HER2 inhibitors, specifically highlighting compound Q7j, which outperforms Mubritinib in suppressing HER2-driven breast cancer cell migration by targeting the epithelial-mesenchymal transition (EMT) pathway. These findings provide new avenues for developing selective HER2 pathway inhibitors and refining preclinical models for breast cancer metastasis.

• XAV-939: Enhancing Wnt/β-Catenin Pathway Assays for Precisio

  2026-07-18

  XAV-939 (NVP-XAV939) is a potent tankyrase inhibitor that empowers researchers to dissect and modulate Wnt/β-catenin signaling in complex disease models, including cancer, fibrosis, and bone biology. Discover actionable workflows, troubleshooting strategies, and key innovations—anchored by recent advances in mesenchymal stem cell research and supported by APExBIO’s robust reagent quality.

• HOXC8 Suppresses Pyroptosis in NSCLC via Caspase-1 Regulatio

  2026-07-17

  This study reveals that HOXC8 overexpression limits pyroptotic cell death in non-small cell lung carcinoma (NSCLC) by repressing caspase-1 transcription. The findings highlight a non-canonical pyroptosis mechanism and suggest new directions for apoptosis and cancer research.

• Camptothecin: Molecular Insights and Research Frontiers in T

  2026-07-17

  Explore the molecular mechanisms and advanced research applications of Camptothecin, a leading topoisomerase I inhibitor, in cancer and genome stability studies. This article uniquely integrates recent findings on protein self-assembly and adaptive mutagenesis to guide experimental design.

• Brefeldin A: Applied Workflows for ER Stress and Cancer Assa

  2026-07-16

  Brefeldin A (BFA) is more than a classic vesicle transport inhibitor—its ability to induce ER stress and apoptosis in cancer cells makes it indispensable for dissecting protein trafficking and cell death pathways. This guide delivers hands-on protocols, troubleshooting tips, and translational insights rooted in the latest research and APExBIO’s manufacturing standards.

• Vincristine Sulfate: Optimizing Microtubule Dynamics in Canc

  2026-07-16

  Vincristine sulfate is a cornerstone for dissecting microtubule dynamics in translational oncology, offering reproducible in vitro and in vivo results. This guide unpacks applied protocols, comparative advantages, and troubleshooting tips to maximize experimental impact using APExBIO’s trusted reagent.

• EZ Cap™ Human PTEN mRNA: Empowering Tumor Suppressor Gene Re

  2026-07-15

  EZ Cap™ Human PTEN mRNA streamlines the restoration of PTEN function in advanced cancer and gene therapy research, offering unmatched stability and translation efficiency. This reagent is pivotal for researchers tackling PI3K/Akt signaling and immune evasion in tumor models.

• Tubastatin A: HDAC6 Inhibitor Transforming Cardiac & Cancer

  2026-07-15

  Tubastatin A, a nanomolar HDAC6 inhibitor from APExBIO, offers precision targeting of epigenetic and cytoskeletal pathways in both cardiac injury and cancer models. Its robust selectivity and proven translational efficacy unlock new experimental workflows in cell death, inflammation, and microtubule stabilization research.

• Ampicillin Sodium: Translational Impact Beyond Antibacterial

  2026-07-14

  This thought-leadership article explores how Ampicillin sodium, a β-lactam antibiotic, transcends its conventional use in antibacterial activity assays to become a pivotal tool in advanced translational research. Integrating mechanistic insights, evidence-based protocols, and strategic guidance, it highlights best practices for employing Ampicillin sodium in recombinant protein workflows, antibiotic resistance studies, and preclinical infection models. By referencing foundational research and incorporating lessons from annexin V purification and current literature, this piece positions APExBIO's Ampicillin sodium as a cornerstone for innovative translational breakthroughs.

• EZ Cap™ Human PTEN mRNA: Optimizing Tumor Suppressor Workflo

  2026-07-14

  EZ Cap™ Human PTEN mRNA empowers reproducible, immune-evasive PTEN restoration for advanced cancer and gene therapy research. Discover practical workflow upgrades, nanoparticle delivery innovations, and data-driven troubleshooting strategies to accelerate your tumor suppressor gene mRNA studies.

• Nile Red for Lipid Droplet Imaging: Protocols and Innovation

  2026-07-13

  Nile Red empowers researchers to visualize lipid droplet dynamics with unmatched specificity and dual-fluorescence flexibility. This guide details actionable workflows, troubleshooting strategies, and leverages new findings on autophagy-lipid interactions for precision lipid metabolism research.

• Reliable Cell Cycle Arrest Research with Dinaciclib (SCH7279

  2026-07-13

  This article guides biomedical researchers through common challenges in cell cycle and apoptosis assays, demonstrating how Dinaciclib (SCH727965), SKU A8412, provides robust, reproducible results. It translates quantitative data and real-world protocol advice into actionable strategies for optimizing CDK inhibitor experiments.

• Evaluating Drug Responses in Cancer: Advances in In Vitro Me

  2026-07-12

  Schwartz's dissertation provides a rigorous analysis of how in vitro assays can more accurately distinguish between drug-induced proliferative arrest and cell death in cancer research. By dissecting the limitations of standard viability metrics, the study offers actionable guidance for improving preclinical evaluation of anticancer compounds.

• IR-820 (New Indocyanine Green): Engineering Precision in Tum

  2026-07-10

  Explore the advanced molecular engineering and methodological innovations that position IR-820 (New Indocyanine Green) as a next-generation vascular and tumor imaging dye. This article reveals unique mechanistic insights and practical workflows for in vivo quantification of diseased tissue.

452 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page